"Designing Growth Strategies is in our DNA"

Enzyme Replacement Therapy Market Size, Share & Industry Analysis, By Drug Class (Alglucosidase alfa, Agalsidase, Pancrelipase, Idursulfase, Laronidase, Imiglucerase, Elosulfase alfa, Asfotasealfa, Galsulfase, Velaglucerase alfa, and Others), By Route of Administration (Parenteral and Oral), By Indication (Type 1 Gaucher Disease, Pompe Disease, MPS (Mucopolysaccharidosis), Exocrine Pancreatic Insufficiency (EPI), Fabry Disease, Hypophosphatasia, and Others), By End User (Hospitals and Homecare Settings & Infusion Centers), and Regional Forecast, 2024-2032

Last Updated: July 01, 2024 | Format: PDF | Report ID: FBI106424

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Speak to Analyst

man icon
Mail icon
Captcha refresh
  • 2019-2032
  • 2023
  • 2019-2022
  • 150






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X